An Objective Fluctuation Score for Parkinson's Disease

被引:69
作者
Horne, Malcolm K. [1 ,2 ]
McGregor, Sarah [2 ]
Bergquist, Filip [3 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia
[2] St Vincents Hosp Melbourne, Ctr Clin Neurosci & Neurol Res, Fitzroy, Vic, Australia
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden
基金
英国医学研究理事会;
关键词
MOTOR FLUCTUATIONS; LEVODOPA; EVOLUTION; PHARMACODYNAMICS; THERAPY;
D O I
10.1371/journal.pone.0124522
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Establishing the presence and severity of fluctuations is important in managing Parkinson's Disease yet there is no reliable, objective means of doing this. In this study we have evaluated a Fluctuation Score derived from variations in dyskinesia and bradykinesia scores produced by an accelerometry based system. Methods The Fluctuation Score was produced by summing the interquartile range of bradykinesia scores and dyskinesia scores produced every 2 minutes between 0900-1800 for at least 6 days by the accelerometry based system and expressing it as an algorithm. Results This Score could distinguish between fluctuating and non-fluctuating patients with high sensitivity and selectivity and was significant lower following activation of deep brain stimulators. The scores following deep brain stimulation lay in a band just above the score separating fluctuators from non-fluctuators, suggesting a range representing adequate motor control. When compared with control subjects the score of newly diagnosed patients show a loss of fluctuation with onset of PD. The score was calculated in subjects whose duration of disease was known and this showed that newly diagnosed patients soon develop higher scores which either fall under or within the range representing adequate motor control or instead go on to develop more severe fluctuations. Conclusion The Fluctuation Score described here promises to be a useful tool for identifying patients whose fluctuations are progressing and may require therapeutic changes. It also shows promise as a useful research tool. Further studies are required to more accurately identify therapeutic targets and ranges.
引用
收藏
页数:11
相关论文
共 11 条
[1]   Automated Assessment of Bradykinesia and Dyskinesia in Parkinson's Disease [J].
Griffiths, Robert I. ;
Kotschet, Katya ;
Arfon, Sian ;
Xu, Zheng Ming ;
Johnson, William ;
Drago, John ;
Evans, Andrew ;
Kempster, Peter ;
Raghav, Sanjay ;
Horne, Malcolm K. .
JOURNAL OF PARKINSONS DISEASE, 2012, 2 (01) :47-55
[2]   THE SYDNEY MULTICENTER STUDY OF PARKINSONS-DISEASE - A RANDOMIZED, PROSPECTIVE 5-YEAR STUDY COMPARING LOW-DOSE BROMOCRIPTINE WITH LOW-DOSE LEVODOPA-CARBIDOPA [J].
HELY, MA ;
MORRIS, JGL ;
REID, WGJ ;
OSULLIVAN, DJ ;
WILLIAMSON, PM ;
RAIL, D ;
BROE, GA ;
MARGRIE, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (08) :903-910
[3]   MOTOR RESPONSE TO LEVODOPA IN PATIENTS WITH PARKINSONIAN MOTOR FLUCTUATIONS - A FOLLOW-UP-STUDY OVER 3 YEARS [J].
HUGHES, AJ ;
FRANKEL, JP ;
KEMPSTER, PA ;
STERN, GM ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (04) :430-434
[4]   Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease [J].
McColl, CD ;
Reardon, KA ;
Shiff, M ;
Kempster, PA .
MOVEMENT DISORDERS, 2002, 17 (06) :1227-1234
[5]   Evolution of the response to levodopa during the first 4 years of therapy [J].
Nutt, JG ;
Carter, JH ;
Lea, ES ;
Sexton, GJ .
ANNALS OF NEUROLOGY, 2002, 51 (06) :686-693
[6]   Short- and long-duration responses to levodopa during the first year of levodopa therapy [J].
Nutt, JG ;
Carter, JH ;
VanHouten, L ;
Woodward, WR .
ANNALS OF NEUROLOGY, 1997, 42 (03) :349-355
[8]   Pharmacokinetics and pharmacodynamics of levodopa [J].
Nutt, John G. .
MOVEMENT DISORDERS, 2008, 23 :S580-S584
[9]  
Papapetropoulos SS, 2011, CNS NEUROSCIENCE THE
[10]  
Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO